Safety and feasibility of adjuvant chemotherapy with S-1 in Japanese breast cancer patients after primary systemic chemotherapy: a feasibility study. - Wikidata - awgldk - TriplyDB

Safety and feasibility of adjuvant chemotherapy with S-1 in Japanese breast cancer patients after primary systemic chemotherapy: a feasibility study.

Safety and feasibility of adjuvant chemotherapy with S-1 in Japanese breast cancer patients after primary systemic chemotherapy: a feasibility study.

http://www.wikidata.org/entity/Q35530220

about

S-1 vs. paclitaxel plus carboplatin as adjuvant chemotherapy for completely resected stage II/IIIA non-small-cell lung cancer.

P2860

Q49236282-531EA9FC-E942-4843-92B3-F4D4606C85C1

P2860

Safety and feasibility of adjuvant chemotherapy with S-1 in Japanese breast cancer patients after primary systemic chemotherapy: a feasibility study.

http://www.wikidata.org/entity/Q35530220

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Safety and feasibility of adju ...... otherapy: a feasibility study.

@ast

Safety and feasibility of adju ...... otherapy: a feasibility study.

@en

type

label

Safety and feasibility of adju ...... otherapy: a feasibility study.

@ast

Safety and feasibility of adju ...... otherapy: a feasibility study.

@en

prefLabel

Safety and feasibility of adju ...... otherapy: a feasibility study.

@ast

Safety and feasibility of adju ...... otherapy: a feasibility study.

@en

P1433

Q35530220-7514102D-B08C-4B80-85BC-2C8890398A7F

P1476

Q35530220-1863637F-ADEF-4C51-927F-C41FCE8CE824

P2093

Q35530220-2035EC1D-E12E-40A6-A1A9-BBE688BA909B

Q35530220-3D87004F-2B49-4EBA-956F-C12E5CA0447D

Q35530220-487C09F4-53D8-4EBC-8444-E1C1B847665C

Q35530220-4E440BB2-4DAA-4781-9EFB-F31BCE47FC6A

Q35530220-53F57810-696F-4F7A-8D73-B8C27C2477BB

Q35530220-54FC9E69-71DB-42D9-B156-E18BD60F2216

Q35530220-585DB646-1BA3-4E97-88CA-16CF01B493A8

Q35530220-649E067E-6603-49FE-8559-3019A41FB7F4

Q35530220-6C17C3AD-1830-40FF-A2D7-DE5D0E1EC191

Q35530220-9931BFB0-7AAF-4138-A918-A29B029AC03D

P2860

Q35530220-00C84666-F7C7-4ED1-8F2B-0C8DF92E8D13

Q35530220-01D23B4A-D8CB-431F-984F-FE1B72312387

Q35530220-1DD3AA0D-09AC-40CA-A491-A69C656173D5

Q35530220-1FD40E10-CBB9-4FC1-A061-FF7B82A3FBB6

Q35530220-499C4BCC-2942-4E1C-92BD-638120B1456D

Q35530220-4FC6A71C-800D-4FB6-9558-567123B709AA

Q35530220-998D739F-56A3-4509-B450-0FECC5A80DF5

Q35530220-A2BE7570-C9B8-4514-8CBB-F5E9799842E0

Q35530220-AB011ECA-20CC-4A00-B55A-6B567722F028

Q35530220-BB2F5926-E1A1-40EC-B961-AF4C0635659A

P2888

Q35530220-83359D6A-38E2-4E5E-8DA9-353F8959DC6F

P304

Q35530220-BCC4CAAF-F926-4882-A6BB-A509DFB459BC

P31

Q35530220-B08E74D5-BD25-49E1-AE22-D61E4A0F73F4

P356

Q35530220-6D54C9EF-23D4-4C43-B404-A7DAC97B9A69

P407

Q35530220-66D81180-C6A4-42E2-BEDC-04C6302B1E77

P478

Q35530220-3261531D-5FAC-4539-A4CE-0445AC12409F

P577

Q35530220-7AE1B949-6A6D-4070-9F0B-D8556EE0DEBC

P5875

Q35530220-F8B6FB3E-A2D5-4B7D-A513-C427F92334CD

P6179

Q35530220-E4EEA505-901F-4204-9527-A86AEB52680B

P698

Q35530220-B7F185F5-3186-4631-B4CC-628B4EBBDE38

P932

Q35530220-430EE42D-7012-41A6-88DB-F3EB7FD8285B

P356

S12885-015-1289-7

P1433

P1476

Safety and feasibility of adju ...... otherapy: a feasibility study.

@en

P2093

Akihiko Osaki

http://www.w3.org/2001/XMLSchema#string

Chizuko Kanbayashi

http://www.w3.org/2001/XMLSchema#string

Eiko Hirokawa

http://www.w3.org/2001/XMLSchema#string

Hideki Takeuchi

http://www.w3.org/2001/XMLSchema#string

Hiroko Shimada

http://www.w3.org/2001/XMLSchema#string

Hiroshi Sano

http://www.w3.org/2001/XMLSchema#string

Hiroshi Sekine

http://www.w3.org/2001/XMLSchema#string

Ikuko Sugitani

http://www.w3.org/2001/XMLSchema#string

Michiko Sugiyama

http://www.w3.org/2001/XMLSchema#string

Nobuaki Sato

http://www.w3.org/2001/XMLSchema#string

P2860

Preoperative chemotherapy for women with operable breast cancer

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update.

Multicenter phase II trial of preoperative chemoradiotherapy with S-1 for locally advanced oral squamous cell carcinoma.

Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006.

Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel.

Phase I study of oral S-1 and concurrent radiotherapy in patients with unresectable locally advanced pancreatic cancer.

The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer.

A phase II study of S-1 in patients with metastatic breast cancer--a Japanese trial by the S-1 Cooperative Study Group, Breast Cancer Working Group.

P2888

s12885-015-1289-7

P304

253

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-015-1289-7

http://www.w3.org/2001/XMLSchema#string

P407

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275048495

http://www.w3.org/2001/XMLSchema#string

P6179

1032206357

http://www.w3.org/2001/XMLSchema#string

P698

25884795

http://www.w3.org/2001/XMLSchema#string

P932

4407316

http://www.w3.org/2001/XMLSchema#string